ArgiNOx Phamaceuticals
Redwood City
About ArgiNOx Phamaceuticals
Arginox Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for cardiovascular pathologies. It offers Tilarginine Acetate Injection that inhibits the production of nitric oxide, which is used for the treatment of cardiogenic shocks. Arginox Pharmaceuticals is based in Redwood City, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $41.3M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2005)
- Website: arginox.com
- Phone: +1 888 274 6070
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/arginox-phamaceuticals-2294551 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.